指南与共识消化、代谢与肾脏急症儿科与产科急症

COVID-19疫情期间急诊与择期肛肠/直肠肛门干预:治疗安全实用指南

Urgent and elective proctologic/anorectal interventions in the COVID-19 pandemic: A practical guideline for treatment safety.
指南 / 共识 · Ulus Travma Acil Cerrahi Derg · 2021-01-01
一句话结论遵循该实用指南原则,在COVID-19疫情初期紧迫期可安全治疗大多数良性肛肠疾病,疑似污染率2.1%且无确诊病例。

本文旨在基于一系列肛肠干预的早期结果,为COVID-19疫情期间常见肛肠疾病的急诊、半紧急和择期处理提供实用信息和具体建议。方法上参考其他相关指南,制定针对高发肛肠疾病诊断治疗的一般原则,包括通过远程医疗正确筛选患者、调整肛肠科单元适应疫情、控制污染和感染。2020年3月1日至4月10日期间在两个中心联系了240例肛肠疾病患者,4月16-17日回顾性评估结果:14例(5.8%)失访,31例(12.9%)评估为不可推迟并邀请至肛肠科,28例同期接受干预。遵循所述原则,超过90%的良性肛肠疾病可成功治疗,疑似污染率2.1%,无确诊病例,肛肠科人员及其密切接触者均未感染COVID-19。

要点

  • 2020年3月1日至4月10日在两个中心联系240例肛肠疾病患者,31例(12.9%)评估为不可推迟并邀请至肛肠科,28例同期接受干预。
  • 遵循指南原则,超过90%的良性肛肠疾病可成功治疗,疑似污染率2.1%,无确诊病例。
  • 肛肠科人员及其密切接触者均未发生COVID-19。
  • 14例(5.8%)在调查结束时失访。
  • 通过远程医疗评估和导向正确患者,并调整肛肠科单元以适应疫情、控制污染和感染。

适用人群与场景

  • 2020年3月1日至4月10日在两个中心联系的240例肛肠疾病患者。

处置流程与药物剂量

  • 通过远程医疗评估和导向正确患者,调整肛肠科单元以适应新疫情,控制污染和感染。
  • 31例(12.9%)评估为不可推迟病例并邀请至肛肠科,其中28例需要同期干预。

研究设计与关键结果

  • 2020年3月1日至4月10日在两个中心联系240例肛肠疾病患者,4月16-17日回顾性评估结果。
  • 14例(5.8%)失访,31例(12.9%)评估为不可推迟并邀请至肛肠科,28例同期接受干预。
  • 遵循所述原则,超过90%的良性肛肠疾病可成功治疗,疑似污染率2.1%,无确诊病例。
  • 肛肠科人员及其密切接触者均未发生COVID-19。

证据类型、等级与局限

  • 证据类型:实用指南,基于回顾性记录的早期结果。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 遵循该实用指南原则,在COVID-19疫情初期紧迫期可安全治疗大多数良性肛肠疾病。
  • 通过远程医疗评估和导向患者,调整肛肠科单元适应疫情,控制污染和感染。

指南或共识出处

  • Ulus Travma Acil Cerrahi Derg

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「红旗征与不能漏的情况」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

BACKGROUND: This article aims to give practical information and concrete suggestions on what should be considered in emergency, semi-urgent and elective settings for common anorectal diseases in the hectic period of the COVID-19 pandemic, based on early results of a series of anorectal interventions.

METHODS: Referring to other related guidelines, general considerations specific to the diagnosis and treatment of highly prevalent anorectal diseases were developed to target the correct patients, evaluate and orientate by telemedicine, adapt the Proctology Unit to the new pandemic, and control contamination and infection. Specific considerations for common anorectal diseases were cited, and our initial results were retrospectively documented.

RESULTS: From March 1 to April 10, 2020, we contacted 240 patients with anorectal diseases in two centers. We evaluated the results retrospectively on 16-17 April. At the end of this survey, 14 patients (5.8%) were lost for further contact and follow-up. Thirty-one patients (12.9%) were evaluated as nondeferrable cases and invited to the Proctology Unit. Twenty-eight patients required interventions at the same session. Adhering to the principles described here, more than 90 percent of benign anorectal disorders could be treated successfully, with 2.1 percent of suspected contamination and no confirmed cases. None of the Proctology personnel or their close contacts developed COVID-19, either.

CONCLUSION: By adhering to the principles outlined in this practical guide, it was possible to treat most of the benign anorectal diseases safely in the initial, hectic period of the COVID-19 pandemic.

来源:Ulus Travma Acil Cerrahi Derg,查看原文。版权归原作者所有。

参考来源

  1. Leventoğlu S, Menteş B, Şenol E, et al. Urgent and elective proctologic/anorectal interventions in the COVID-19 pandemic: A practical guideline for treatment safety. Ulus Travma Acil Cerrahi Derg. 2021. PMID: 33630284. doi:10.14744/tjtes.2020.02446

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。